Inactive Instrument

Theradiag Stock

ALTER

FR0004197747

News in other languages : Theradiag

20/12/23	Theradiag : Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
18/12/23	Biosynex : réalisation de la fusion-absorption de Theradiag
18/12/23	Bolsa de Madrid: Los bancos centrales se lanzan a por los toros
18/12/23	Capelli : Eiffage, Renault, Tikehau Capital... les valeurs à suivre aujourd'hui à Paris
18/12/23	En Direct des Marchés : Vivendi, Teleperformance, Renault, Carrefour, Casino, Eurazeo, Unilever...

More news

Managers and Directors : Theradiag

Manager	Title	Age	Since
Bertrand Michel Marle de Castelnau CEO	Chief Executive Officer	65	21/01/2019
Muriel Bardet DFI	Director of Finance/CFO	-	-

Director	Title	Age	Since
Christian Policard CHM	Chairman	-	-
Thierry Paper BRD	Director/Board Member	63	05/05/2022
Larry Abensur BRD	Director/Board Member	71	05/05/2022

More insiders

Theradiag develops, produces, and sells in vitro diagnostic kits for detecting auto-immune diseases, allergies, and infectious diseases. The group also offers theranostic tests for monitoring biotherapies and determining patient response to treatments applied. 54.6% of net sales are abroad.

Employees

Sector

More about the company

18/12/23	Biosynex: merger with Theradiag completed
22/09/23	Theradiag SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
18/09/23	Theradiag: improved first-half profitability
17/07/23	Theradiag: 7% growth in half-year sales
17/07/23	Theradiag SA Reports Audited Revenue Results for the Second Quarter and First Half Ended on June 30, 2023	CI
27/04/23	Theradiag SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
01/03/23	Theradiag SA Announces Executive Changes	CI
01/03/23	Theradiag SA Announces Management Changes	CI
31/01/23	Biosynex SA completed the acquisition of additional 46.52% stake in Theradiag SA for €21.6 million.	CI
18/01/23	Biosynex: takeover bid reopened for Theradiag shares
17/01/23	Theradiag: takeover bid reopened on January 18
16/01/23	Theradiag: 2022 sales without surprises
16/01/23	Biosynex: successful takeover bid for Theradiag

17/11/23	Q-linea signs distribution partnership for Benelux	AQ
16/01/23	Theradiag : Inside Information / News release on accounts, results	PU
06/01/23	Theradiag : Inside Information / Other news releases	PU
23/09/22	Theradiag : News releases during takeover bids / Takeover bids Other news releases	PU
26/10/21	26/10/2021: Theradiag launches a Rights Issue	PU

Theradiag Stock

Stocks

ALTER

FR0004197747

Latest news : Theradiag

Press Releases : Theradiag

News in other languages : Theradiag

Managers and Directors : Theradiag

Latest insider transactions

Company Profile